In addition, the further analysis of clonal architecture and prognostic significance of the driver mutations allowed us to identify a novel candidate gene, Gnb2. Finally we confirmed its functional relevance by in vitro and in vivo experiments of mouse MLL/AF9 leukemia, a cytokine-dependent Ba/F3, and human hematopoietic cell lines. This evidence concerns the gene MLLT3 and leukemia.